Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Sep 24, 2022

Are there FDA-approved medications for eating disorders? In this episode, we discuss management strategies for eating disorders, including the use of FDA-approved medications, the importance of cognitive–behavioral interventions, and the need to reduce stigma in these disorders. 

Guest: Timothy Brewerton,...


Sep 19, 2022

What are the contraindications to antipsychotic switching? This episode discusses the relative contraindications of antipsychotic switching, including recent recovery from an acute psychotic episode, current stability on an LAI, and history of violence or severe symptoms. 

Faculty: Brian Miller, M.D. 
Host: Jessica...


Sep 14, 2022

Why do patients stop clozapine? 
This episode discusses clozapine discontinuation rates and reasons for doing so among patients who later recommenced clozapine therapy. 

Faculty: Jim Phelps, M.D. 
Host: Jessica Diaz, M.D.


Sep 9, 2022

Sharpen your clinical skills with a clinical case of an adolescent girl with OCD. This episode also reviews the progression and consequences of the patient’s symptoms, the diagnosis, and the best treatment options for improving her symptoms. 

Faculty: David Rosenberg, M.D. 
Host: Jessica Diaz, M.D.


Sep 4, 2022

In this episode, Dr. Phelps discusses a study on the efficacy and safety of mirtazapine for treating agitation in patients with dementia. Would prescribing mirtazapine be worth the risk? 

Faculty: Jim Phelps, M.D. 
Host: Jessica Diaz, M.D.